SCOTTSDALE, Arizona, October 25, 2013 – Provista Diagnostics, Inc., a leading molecular diagnostics company focused on developing and commercializing proprietary diagnostic, prognostic and predictive tests for cancers affecting women, has licensed a series of biomarker technologies developed by researchers at the Biodesign Institute of Arizona State University. Provista will evaluate the technologies for use in the early detection of breast cancer, ovarian cancer and HPV.
ASU News: 02/23/2012
Heliae, a technology-development company based in Chandler, is working to design an industrial process that starts with the creation of high-fat strains of algae and ends with the production of jet fuel and other commercial products.
Fluidic Energy, located in Scottsdale, is dedicated to transforming the way electricity is generated, delivered and consumed through an innovative energy storage approach. Its core technology enables a lower cost and its high energy density delivers ultra-long run times in comparison to traditional batteries.Continue reading